Michael Clayman

Michael Clayman

Presidente en
Anokion SA
.
74 años
Health Technology
Consumer Services
Industrial Services

Perfil

Michael D.
Clayman
is the founder of Flexion Therapeutics, Inc., which was founded in 2007.
He held the title of President, Chief Executive Officer & Director from 2018 to 2021.
Currently, he is the Non-Executive Chairman at Anokion SA since 2016, Chairman at Ribometrix, Inc. since 2019, Chairman at Nido Biosciences, Inc. since 2022, and Director at Kanyos Bio, Inc. He previously worked as an Independent Director at Akebia Therapeutics, Inc. from 2014 to 2018.
He also held positions at Eli Lilly & Co., Abbott Cardiovascular Systems, Inc., Chorus Group Ltd., Lilly Research Laboratories, and Perelman School of Medicine.
He completed his undergraduate degree at Yale University and obtained a doctorate from UC San Diego School of Medicine.

Cargos activos de Michael Clayman

EmpresasCargoInicio
Presidente 14/06/2018
Director/Miembro de la Junta -
Presidente 27/09/2019
Presidente 01/08/2022

Antiguos cargos conocidos de Michael Clayman.

EmpresasCargoFin
FLEXION THERAPEUTICS, INC. Director Ejecutivo 19/11/2021
AKEBIA THERAPEUTICS, INC. Director/Miembro de la Junta 12/12/2018
Corporate Officer/Principal 01/01/2007
Consejero General -
ELI LILLY AND COMPANY Corporate Officer/Principal -
Ver el detalle de la experiencia de Michael Clayman.

Formación de Michael Clayman.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

67

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Health Technology

Health Technology

Health Technology

Industrial Services

Consumer Services

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

-40%: ¡Descubre las mejores inversiones del futuro con las herramientas para suscriptores!
d
:
:
APROVECHAR LA PROMOCIÓN